Trials / Completed
CompletedNCT05215210
The Effect of Long-term Momordica Charantia Supplementation on Blood Glucose Levels
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Wageningen University and Research · Academic / Other
- Sex
- All
- Age
- 40 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The study is a parallel, double blind, controlled trial in which study participants will receive a 12-week intervention with 3.6 g/d dried bitter-gourd supplements or a reference intervention with 3.6 g/d dried cucumber supplements. Research subjects will come to the research facility for a test day on four occasions, with an interval of 4 weeks. The main study parameter is fasting levels of plasma glucose.
Detailed description
Bitter gourd (BG) (Momordica charantia) is a highly nutritive vegetable from the cucumber family. The objective is to assess the impact of 12-weeks of BG supplementation on blood glucose levels in subjects with impaired fasting glucose levels. In a previous trial (Bitter-Zoet NL70259.081.19) the short-term effects of BG (4 weeks) were studied, but no effect was observed. In the current trial a different BG cultivar is chosen, the intervention period is prolonged, the dosage per day is higher and study subjects with slightly higher fasting blood glucose levels will be included. The study is a parallel, double blind, controlled trial in which study participants will receive a 12-week intervention with 3.6 g/d dried bitter-gourd supplements or a reference intervention with 3.6 g/d dried cucumber supplements. Research subjects will come to the research facility for a test day on four occasions, with an interval of 4 weeks. The main study parameter is fasting levels of plasma glucose. Secondary outcome measures are glucose tolerance, HbA1c, insulin and HOMA-IR and HOMA-B levels.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Bitter-gourd | 12-week intervention of 3.6 grams of dried bitter-gourd supplements |
| OTHER | Cucumber | 12-week intervention of 3.6 grams of cucumber supplements |
Timeline
- Start date
- 2022-03-23
- Primary completion
- 2022-06-30
- Completion
- 2022-06-30
- First posted
- 2022-01-31
- Last updated
- 2022-11-07
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT05215210. Inclusion in this directory is not an endorsement.